Operating and investment executive focused on growth-stage technology and healthcare opportunities, Robin Gould combines operating leadership with private equity and venture experience across product, commercial strategy and M&A. Known for scaling teams, driving go-to-market expansion and executing strategic exits, she works with boards and management on capital raises, operational transformation and portfolio value creation. Fluent in cross-border transactions and C-suite advisory.
Operating and investment executive focused on growth-stage technology and healthcare opportunities, Robin Gould combines operating leadership with private equity and venture experience across product, commercial strategy and M&A. Known for scaling teams, driving go-to-market expansion and executing strategic exits, she works with boards and management on capital raises, operational transformation and portfolio value creation. Fluent in cross-border transactions and C-suite advisory.
Grows venture and growth-stage tech and healthcare businesses through hands-on operational investing, prioritizing companies with product-market fit and scalable go-to-market motion. Capital allocation favors follow-on support and structured growth rounds tied to performance milestones. Emphasizes operator-led value creation, rigorous commercial KPIs, cross-border M&A optionality and board-level governance to accelerate exits over a medium-term horizon while preserving downside through active portfolio oversight.
Grows venture and growth-stage tech and healthcare businesses through hands-on operational investing, prioritizing companies with product-market fit and scalable go-to-market motion. Capital allocation favors follow-on support and structured growth rounds tied to performance milestones. Emphasizes operator-led value creation, rigorous commercial KPIs, cross-border M&A optionality and board-level governance to accelerate exits over a medium-term horizon while preserving downside through active portfolio oversight.
| Trades 940 | Longs Won 695/940 73% | Profit Factor 54.08 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $546,637.82 |
| Average Win $101,274.23 | Best Trade (Jul 15) $11.93M | Sharpe Ratio -11.59 |
| Average Loss -$5,312.01 | Worst Trade (Jul 15) -$225,688.15 | Z-Score 7.3 (100%) |
| Commissions $0 | Avg. Trade Length 1y 4m | Expectancy $73,493.77 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% |
| Consecutive Losing Trades | 47,619 | 42,857 | 38,095 | 33,333 | 28,571 | 23,810 | 19,048 | 14,286 | 9,524 | 4,762 |